# Semaglutide Maintenance Dose: What the Label Says

**By telos rx Editorial Team** · 2026-11-13

**The semaglutide maintenance dose is the weekly dose a provider keeps you on once titration ends. The Wegovy label names it, but the right dose for you is a provider decision. telos rx offers [microdosed tirzepatide](https://telosrx.com/pages/microdosed-tirzepatide) for maintenance-minded plans.**

Search for "semaglutide maintenance dose" and you will find charts, forum threads and wildly different numbers. Some say stay at the top dose forever. Others say drop low and coast. Here is what the FDA label actually says, what the research tested, and where the guesswork starts.

## What "maintenance dose" means

A maintenance dose is the steady dose you stay on after the step-up phase. Semaglutide starts low and rises every few weeks. That slow climb gives your gut time to adjust.

Once the climb stops, you are on a maintenance dose. It is meant to hold the effect, not to keep pushing it higher. Think of it as cruising speed after the on-ramp.

People use the phrase in two ways, which causes confusion:

-   **Label maintenance.** The dose the FDA label names as the end of titration.
-   **Weight maintenance.** A dose used after you reach a goal weight, to help hold it.

These are not always the same number. The second meaning is where most of the online debate lives.

## What the Wegovy label says

Wegovy is an FDA-approved brand of semaglutide for weight reduction. Its label is the clearest source on maintenance dosing ([Wegovy label, DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)).

For weight reduction in adults, the label names a once-weekly maintenance dosage of 2.4 mg as recommended, with 1.7 mg as the other option. It tells prescribers to weigh treatment response and tolerability when choosing between them.

The current label also allows a higher dose for some adults. People who tolerate 2.4 mg for at least 4 weeks may move up, if more weight reduction is clinically indicated. That decision belongs to the prescriber.

Notice what the label does not do. It does not name a lower "goal weight" dose. It does not describe stepping down after you hit a target. Those ideas come from clinical practice and online discussion, not from the label.

## What the Ozempic label says

Ozempic is an FDA-approved brand of semaglutide for type 2 diabetes. It is not labelled for weight loss. Its maintenance dosage is set by blood sugar control, not by weight.

Many people still search for Ozempic doses when they mean weight maintenance. That mixes up two products with two different jobs. If you are on Ozempic, your diabetes care team sets your dose.

## Average semaglutide maintenance dose: is there one?

People often ask for the average semaglutide maintenance dose. The honest answer is that no single average applies to you.

In the big Wegovy trials, participants were pushed to the 2.4 mg dose by design. That tells you what the trials tested. It does not tell you what most real-world patients end up taking.

Real-world use is messier. Some people stop climbing because of nausea. Some pause because of cost or supply. Some providers hold a lower dose on purpose. An "average" across all of that says little about your own body.

A better question is this: what dose holds your progress with side effects you can live with? Only your provider can answer that, using your history and how you respond.

## Best maintenance dose for semaglutide

There is no best maintenance dose for semaglutide in general. There is only the dose that fits a specific person at a specific time.

Your provider will usually weigh things like these:

-   How your weight has changed, and whether it is stable.
-   Which side effects you have, and how strong they are.
-   Your other conditions, such as blood sugar, blood pressure or kidney health.
-   Your other medications and supplements.
-   Your goals now, which may differ from your goals at the start.

The label backs this up. It tells prescribers to consider response and tolerability. That is clinical judgment, not a formula you can copy from a chart.

Thinking about maintenance?

telos rx offers microdosed tirzepatide, a weekly injection dosed by your provider and subject to medical approval by a licensed provider. As low as $116 per month as of publication.

[See microdosed tirzepatide](https://telosrx.com/pages/microdosed-tirzepatide)

## What happens if you stop semaglutide

This is the part most charts skip. Stopping semaglutide often leads to weight regain. The research on this is clear.

The STEP 4 trial tested it directly ([STEP 4, JAMA 2021](https://pubmed.ncbi.nlm.nih.gov/33755728/)). Everyone first climbed to 2.4 mg over 20 weeks. Then some stayed on semaglutide and some were switched to placebo.

The group that stayed on kept losing weight over the next 48 weeks. The group switched to placebo regained weight. The researchers concluded that ongoing treatment was needed to keep the benefit.

This is why maintenance matters. For many people, obesity behaves like a long-term condition. When the medication stops, appetite signals often return to where they were.

## Microdosing semaglutide for maintenance

Microdosing semaglutide for maintenance means using a dose below the labelled maintenance range after weight loss. It is a popular idea online. It is also one of the least studied.

First, a key fact. "Microdosing" is not an FDA-recognised dosing category. It means a provider-prescribed dose below the standard labelled titration schedule. That is off-label use.

The published evidence for sub-label doses is limited. STEP 4 tested staying on the full dose versus stopping. It did not test a lower middle path.

A 2026 real-world records study looked at people who stayed on the lowest labelled starting doses for months ([Murugadoss et al., 2026](https://pubmed.ncbi.nlm.nih.gov/42857675/)). The authors were careful. They said this pattern may overlap with microdosing but does not prove it was intentional.

That study found modest average weight change on sustained low doses. It also reported side effects at those doses. The authors called for prospective trials. In plain terms, the question is still open.

## How the approaches compare

Here is a quick look at what each maintenance approach has behind it. This is a summary of evidence, not a plan to follow.

| Approach | On the label? | What research shows |
| --- | --- | --- |
| Stay on the labelled maintenance dose | Yes | Held and extended weight loss in STEP 4 |
| Stop the medication | Not a dosing option | Weight regain in STEP 4 |
| Step down to a lower labelled dose | Partly, by tolerability | Little direct trial data for weight holding |
| Microdose below the labelled range | No, off-label | Limited, mostly observational |
| Stretch the time between doses | No  | No published trial |

## Semaglutide maintenance dose after goal weight

Reaching a goal weight is a big moment. It is also when many people want to cut back. That instinct makes sense, especially if side effects or cost have been hard.

Still, the label does not set a separate dose for after goal weight. Any change at that point is a provider call. Some providers hold the current dose. Some test a lower dose and watch closely. Some discuss tapering.

Whatever the plan, it should come with check-ins. Your weight, appetite and side effects tell your provider whether the plan is holding. If weight starts climbing, the plan may need to change again.

For a side-by-side look at those two paths, read [microdosing vs tapering GLP-1](/blogs/glp1/microdosing-vs-tapering-glp-1).

## Every other week or once a month?

Some people ask about semaglutide every other week, or even once a month. The idea is to space doses out and save money.

The Wegovy label is once weekly. Semaglutide has a long half-life of about a week. Longer gaps change how much drug stays in your system between doses.

No published trial supports every-other-week or monthly semaglutide for weight maintenance. If cost is pushing you toward a longer gap, tell your provider. That is a solvable problem, and guessing is not the safe way to solve it.

## Why online dose charts are risky

Charts that list semaglutide maintenance doses "in units" are common. They are also a known source of harm.

Compounded semaglutide comes in different strengths from different pharmacies. A number that fits one vial can be wrong for another. The FDA has warned about dosing errors with compounded semaglutide tied to this kind of confusion.

Compounded semaglutide is also not FDA-approved. It is not the same product as Wegovy or Ozempic. A chart built around one product does not transfer to another.

The safe rule is simple. Your dose comes from your prescriber and your pharmacy label. Not from a screenshot. For more on this, see our [microdosing semaglutide dosage chart](/blogs/glp1/microdosing-semaglutide-dosage-chart) explainer.

## Where tirzepatide fits

telos rx does not offer a microdosed semaglutide product. Its microdose option is compounded tirzepatide. Tirzepatide acts on two receptors, GIP and GLP-1, while semaglutide acts on GLP-1 alone.

If you want standard semaglutide care, telos rx has a separate [semaglutide](https://telosrx.com/pages/semaglutide) page. If you are interested in a lower-dose, maintenance-minded plan, the microdose option is tirzepatide.

Compounded tirzepatide is not FDA-approved. It is not the same product as Zepbound or Mounjaro. Switching between semaglutide and tirzepatide is a provider decision, made with your history in view.

To compare the two molecules at low doses, read [microdosing tirzepatide vs semaglutide](/blogs/glp1/microdose-tirzepatide-vs-semaglutide). For the tirzepatide side of this topic, see [tirzepatide maintenance dose](/blogs/glp1/tirzepatide-maintenance-dose).

## Questions to bring to your provider

A good maintenance plan starts with a clear conversation. These questions help:

1.  Is my current dose a maintenance dose, or am I still titrating?
2.  What signs would tell us the dose is too high or too low?
3.  If I reach my goal, what is the plan for the next six months?
4.  How often should I report my weight and side effects?
5.  Would a different medication suit me better long term?
6.  What happens to my plan if cost or supply changes?

Write the answers down. A plan you understand is easier to stick with.

It also helps to track a few simple things between check-ins. Note your weekly weight on the same scale. Note your appetite, energy and any stomach symptoms. Note anything that changed, such as a new medication, an illness or a stressful month. Those notes give your provider real data to work with, instead of memory alone.

## How telos rx handles maintenance

telos rx is an asynchronous telehealth service. You complete an intake online. A licensed provider reviews it. Every plan is subject to medical approval by a licensed provider.

If you are prescribed microdosed tirzepatide, it is a weekly subcutaneous injection. Your provider sets the dose and adjusts it over time. Medication ships ready to inject, so there is no mixing or dose math at home.

You can message your care team as things change. That matters most during maintenance, when small shifts in appetite or weight are the early signals.

## The bottom line

The Wegovy label names 2.4 mg weekly as the recommended maintenance dose for weight reduction, with 1.7 mg as an option. Stopping often leads to regain, as STEP 4 showed. Lower, off-label maintenance doses have limited evidence so far.

Your maintenance dose should come from a provider who knows your history. Use the research to ask better questions, not to set your own dose.

For a broader view of long-term care, read [GLP-1 maintenance: what long-term treatment looks like](/blogs/glp1/glp1-long-term-maintenance).

Plan your next phase with a provider

Start a private, asynchronous evaluation for microdosed tirzepatide. Every plan is subject to medical approval by a licensed provider.

[Check if you qualify](https://telosrx.com/pages/microdosed-tirzepatide)

## Frequently Asked Questions

### What is the semaglutide maintenance dose for weight loss?

For weight reduction in adults, the Wegovy label names 2.4 mg once weekly as the recommended maintenance dosage, with 1.7 mg as the other option. Some adults who tolerate 2.4 mg may move higher if clinically indicated. Your prescriber chooses the dose based on your response and side effects. Do not change it on your own.

### What is the average semaglutide maintenance dose?

There is no single average that applies to you. Trials pushed participants to 2.4 mg by design, while real-world doses vary with side effects, cost and goals. The right question is which dose holds your progress with tolerable side effects. Your provider answers that using your history and how you respond over time.

### What is the best maintenance dose for semaglutide?

No dose is best for everyone. The label tells prescribers to weigh treatment response and tolerability when choosing a maintenance dose. Your weight trend, side effects, other conditions and medications all matter. A provider can adjust the dose as these change. Charts online cannot account for any of that.

### Can I microdose semaglutide for maintenance?

Microdosing semaglutide for maintenance is off-label and has limited evidence. Microdosing is not an FDA-recognised dosing category. STEP 4 compared staying on the full dose with stopping, not a lower dose. telos rx does not offer microdosed semaglutide. Its microdose option is compounded tirzepatide, which is not FDA-approved.

### What happens if I stop semaglutide after reaching my goal?

Research shows many people regain weight after stopping. In the STEP 4 trial, people switched to placebo regained weight, while those who continued kept losing. That does not mean everyone must stay on the same dose forever. It means any change should be planned and monitored by your provider.

### Can I take semaglutide every other week for maintenance?

The Wegovy label sets semaglutide injection as once weekly. Semaglutide has a half-life of about one week, and no published trial supports every-other-week or monthly dosing for weight maintenance. If cost or side effects make weekly dosing hard, talk to your provider about other options before changing anything.

_telos rx is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service._

Ready to see if it fits? [Start your private evaluation with telos rx](https://telosrx.com/pages/microdosed-tirzepatide).

**Tags:** cc-116, content-calendar, GLP-1 maintenance, maintenance dose, microdosed tirzepatide, microdosing-cluster, semaglutide, weight maintenance

---

> Source: [Telos RX](https://www.telosrx.com/blogs/glp1/semaglutide-maintenance-dose)
